Plain-English translation of NCT06372925 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a medication called to see if it can help people who have just had a heart attack and have high cholesterol. Half of the participants will receive along with a standard cholesterol medication (), while the other half will receive only the standard medication. Doctors will use special imaging tools to look inside the arteries and measure whether the medication helps reduce the buildup of plaque.
Even when patients take standard cholesterol medications after a heart attack, many still have dangerously high cholesterol and ongoing plaque buildup in their arteries. This trial is exploring whether this medication can provide extra protection by lowering cholesterol more effectively and potentially helping the body heal from heart disease.
You will be randomly assigned to receive either the new medication plus a standard cholesterol pill, or the standard pill alone. The new medication is given by injection under the skin three times over the year (at the start, at 3 months, and at 9 months). You'll have regular clinic visits where doctors will check your cholesterol levels and heart health, and you'll undergo special imaging of your arteries at the beginning and end of the study to see how the treatment is working. The entire study lasts about one year.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
China